Avalo Reports 2023 Financial Results and Provides Business UpdatesGlobe Newswire • about 2 months agoAcquired AVTX-009, Phase-2 ready anti-IL-1 mAb, in March 2024Increased cash position with private placement financing in March 2024 providing up to $185 million, including initial upfront investment...